Brief: Shanghai Junshi Biosciences's Prelim 2023 Net Loss 2.2 Bln Yuan
Feb 23 (Reuters) - Shanghai Junshi Biosciences Co Ltd
688180.SS :
* SAYS PRELIM 2023 NET LOSS OF 2.2 BILLION YUAN ($305.64
million)
Source text
Further company coverage: 688180.SS
($1 = 7.1980 Chinese yuan renminbi)
(Reporting by Beijing newsroom)
((Ella.Cao@thomsonreuters.com;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab